nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP2C9—brain cancer	0.682	1	CbGaD
Triazolam—CYP3A4—Temozolomide—brain cancer	0.0198	0.324	CbGbCtD
Triazolam—CYP3A4—Lomustine—brain cancer	0.0168	0.275	CbGbCtD
Triazolam—CYP3A5—Etoposide—brain cancer	0.0104	0.171	CbGbCtD
Triazolam—CYP2C8—Etoposide—brain cancer	0.01	0.164	CbGbCtD
Triazolam—Slurred speech—Procarbazine—brain cancer	0.00457	0.032	CcSEcCtD
Triazolam—CYP3A4—Etoposide—brain cancer	0.00406	0.0665	CbGbCtD
Triazolam—GABRG1—ganglion—brain cancer	0.00347	0.0313	CbGeAlD
Triazolam—Dysarthria—Lomustine—brain cancer	0.0034	0.0238	CcSEcCtD
Triazolam—GABRA6—hindbrain—brain cancer	0.00261	0.0236	CbGeAlD
Triazolam—Disorientation—Lomustine—brain cancer	0.00261	0.0183	CcSEcCtD
Triazolam—Visual disturbance—Lomustine—brain cancer	0.00246	0.0172	CcSEcCtD
Triazolam—Osteoarthritis—Lomustine—brain cancer	0.00234	0.0163	CcSEcCtD
Triazolam—GABRA2—ganglion—brain cancer	0.00232	0.0209	CbGeAlD
Triazolam—Ataxia—Lomustine—brain cancer	0.0022	0.0154	CcSEcCtD
Triazolam—Dysarthria—Procarbazine—brain cancer	0.00216	0.0151	CcSEcCtD
Triazolam—Hearing impaired—Procarbazine—brain cancer	0.00215	0.015	CcSEcCtD
Triazolam—Nightmare—Procarbazine—brain cancer	0.00197	0.0138	CcSEcCtD
Triazolam—GABRB2—hindbrain—brain cancer	0.00193	0.0174	CbGeAlD
Triazolam—GABRQ—telencephalon—brain cancer	0.00192	0.0173	CbGeAlD
Triazolam—GABRA2—hindbrain—brain cancer	0.00176	0.0159	CbGeAlD
Triazolam—Stomatitis—Lomustine—brain cancer	0.00175	0.0123	CcSEcCtD
Triazolam—TSPO—blood vessel—brain cancer	0.00171	0.0154	CbGeAlD
Triazolam—GABRA1—hindbrain—brain cancer	0.0017	0.0153	CbGeAlD
Triazolam—Disorientation—Procarbazine—brain cancer	0.00166	0.0116	CcSEcCtD
Triazolam—Deafness—Procarbazine—brain cancer	0.00166	0.0116	CcSEcCtD
Triazolam—Memory impairment—Temozolomide—brain cancer	0.00157	0.011	CcSEcCtD
Triazolam—Visual impairment—Lomustine—brain cancer	0.00156	0.0109	CcSEcCtD
Triazolam—GABRA6—brainstem—brain cancer	0.0015	0.0135	CbGeAlD
Triazolam—Thinking abnormal—Carmustine—brain cancer	0.0014	0.00977	CcSEcCtD
Triazolam—Ataxia—Procarbazine—brain cancer	0.00139	0.00975	CcSEcCtD
Triazolam—GABRD—telencephalon—brain cancer	0.00139	0.0125	CbGeAlD
Triazolam—GABRG3—pituitary gland—brain cancer	0.00137	0.0123	CbGeAlD
Triazolam—GABRG1—telencephalon—brain cancer	0.00134	0.0121	CbGeAlD
Triazolam—GABRA6—telencephalon—brain cancer	0.00133	0.012	CbGeAlD
Triazolam—Coordination abnormal—Carmustine—brain cancer	0.0013	0.00911	CcSEcCtD
Triazolam—Hearing impaired—Temozolomide—brain cancer	0.0013	0.00908	CcSEcCtD
Triazolam—GABRB1—telencephalon—brain cancer	0.0013	0.0117	CbGeAlD
Triazolam—GABRA5—telencephalon—brain cancer	0.00129	0.0116	CbGeAlD
Triazolam—Disorientation—Hydroxyurea—brain cancer	0.00128	0.00898	CcSEcCtD
Triazolam—Hepatic failure—Hydroxyurea—brain cancer	0.00128	0.00893	CcSEcCtD
Triazolam—Coordination abnormal—Temozolomide—brain cancer	0.00126	0.0088	CcSEcCtD
Triazolam—Sweating increased—Procarbazine—brain cancer	0.00125	0.00873	CcSEcCtD
Triazolam—Depressed level of consciousness—Carmustine—brain cancer	0.00123	0.00863	CcSEcCtD
Triazolam—GABRQ—head—brain cancer	0.00119	0.0108	CbGeAlD
Triazolam—GABRR3—head—brain cancer	0.00119	0.0108	CbGeAlD
Triazolam—Depressed level of consciousness—Temozolomide—brain cancer	0.00119	0.00834	CcSEcCtD
Triazolam—GABRA4—telencephalon—brain cancer	0.00117	0.0106	CbGeAlD
Triazolam—Drowsiness—Procarbazine—brain cancer	0.00114	0.00799	CcSEcCtD
Triazolam—Pain—Carboplatin—brain cancer	0.00112	0.00785	CcSEcCtD
Triazolam—Jaundice—Procarbazine—brain cancer	0.00111	0.00779	CcSEcCtD
Triazolam—Stomatitis—Procarbazine—brain cancer	0.00111	0.00779	CcSEcCtD
Triazolam—Mental disability—Carmustine—brain cancer	0.00111	0.00776	CcSEcCtD
Triazolam—GABRB2—brainstem—brain cancer	0.0011	0.00995	CbGeAlD
Triazolam—Anorexia—Lomustine—brain cancer	0.00109	0.00766	CcSEcCtD
Triazolam—GABRD—medulla oblongata—brain cancer	0.00109	0.00985	CbGeAlD
Triazolam—GABRQ—central nervous system—brain cancer	0.00109	0.00982	CbGeAlD
Triazolam—Mental disability—Temozolomide—brain cancer	0.00107	0.0075	CcSEcCtD
Triazolam—GABRB1—pituitary gland—brain cancer	0.00106	0.00953	CbGeAlD
Triazolam—GABRG1—medulla oblongata—brain cancer	0.00105	0.00948	CbGeAlD
Triazolam—GABRG3—head—brain cancer	0.00105	0.00942	CbGeAlD
Triazolam—GABRR2—head—brain cancer	0.00103	0.00933	CbGeAlD
Triazolam—Hallucination—Procarbazine—brain cancer	0.00102	0.00714	CcSEcCtD
Triazolam—GABRB1—medulla oblongata—brain cancer	0.00102	0.00919	CbGeAlD
Triazolam—GABRA2—brainstem—brain cancer	0.00101	0.00909	CbGeAlD
Triazolam—Deafness—Temozolomide—brain cancer	0.001	0.00701	CcSEcCtD
Triazolam—GABRD—midbrain—brain cancer	0.000998	0.009	CbGeAlD
Triazolam—Decreased appetite—Lomustine—brain cancer	0.000998	0.00698	CcSEcCtD
Triazolam—Hepatic failure—Temozolomide—brain cancer	0.000997	0.00698	CcSEcCtD
Triazolam—GABRR1—head—brain cancer	0.000996	0.00898	CbGeAlD
Triazolam—Amnesia—Carmustine—brain cancer	0.000987	0.00691	CcSEcCtD
Triazolam—GABRB2—telencephalon—brain cancer	0.000979	0.00883	CbGeAlD
Triazolam—GABRG2—telencephalon—brain cancer	0.000979	0.00883	CbGeAlD
Triazolam—GABRA1—brainstem—brain cancer	0.000974	0.00879	CbGeAlD
Triazolam—GABRG1—midbrain—brain cancer	0.000961	0.00866	CbGeAlD
Triazolam—Amnesia—Temozolomide—brain cancer	0.000954	0.00668	CcSEcCtD
Triazolam—GABRG3—central nervous system—brain cancer	0.000954	0.0086	CbGeAlD
Triazolam—GABRA4—pituitary gland—brain cancer	0.000953	0.00859	CbGeAlD
Triazolam—GABRP—pituitary gland—brain cancer	0.000946	0.00853	CbGeAlD
Triazolam—GABRG1—spinal cord—brain cancer	0.000937	0.00845	CbGeAlD
Triazolam—TSPO—brainstem—brain cancer	0.000933	0.00842	CbGeAlD
Triazolam—GABRB1—midbrain—brain cancer	0.000932	0.0084	CbGeAlD
Triazolam—Dysuria—Hydroxyurea—brain cancer	0.000927	0.00649	CcSEcCtD
Triazolam—GABRR2—cerebellum—brain cancer	0.000923	0.00832	CbGeAlD
Triazolam—CYP3A7—endocrine gland—brain cancer	0.000919	0.00829	CbGeAlD
Triazolam—GABRR1—central nervous system—brain cancer	0.000909	0.0082	CbGeAlD
Triazolam—GABRB1—spinal cord—brain cancer	0.000909	0.0082	CbGeAlD
Triazolam—GABRA2—telencephalon—brain cancer	0.000895	0.00807	CbGeAlD
Triazolam—Drowsiness—Hydroxyurea—brain cancer	0.000884	0.00619	CcSEcCtD
Triazolam—Affect lability—Temozolomide—brain cancer	0.000882	0.00617	CcSEcCtD
Triazolam—Tension—Procarbazine—brain cancer	0.000876	0.00613	CcSEcCtD
Triazolam—Ataxia—Carmustine—brain cancer	0.000872	0.0061	CcSEcCtD
Triazolam—Nervousness—Procarbazine—brain cancer	0.000867	0.00607	CcSEcCtD
Triazolam—GABRD—head—brain cancer	0.000865	0.0078	CbGeAlD
Triazolam—GABRQ—brain—brain cancer	0.000865	0.0078	CbGeAlD
Triazolam—GABRA1—telencephalon—brain cancer	0.000865	0.0078	CbGeAlD
Triazolam—Stomatitis—Hydroxyurea—brain cancer	0.000862	0.00603	CcSEcCtD
Triazolam—Mood swings—Temozolomide—brain cancer	0.000849	0.00594	CcSEcCtD
Triazolam—Ataxia—Temozolomide—brain cancer	0.000843	0.0059	CcSEcCtD
Triazolam—Tremor—Procarbazine—brain cancer	0.000837	0.00585	CcSEcCtD
Triazolam—GABRG1—head—brain cancer	0.000833	0.00751	CbGeAlD
Triazolam—GABRA6—head—brain cancer	0.000828	0.00747	CbGeAlD
Triazolam—TSPO—telencephalon—brain cancer	0.000828	0.00747	CbGeAlD
Triazolam—Muscular weakness—Carmustine—brain cancer	0.000818	0.00572	CcSEcCtD
Triazolam—GABRB1—head—brain cancer	0.000808	0.00728	CbGeAlD
Triazolam—GABRA5—head—brain cancer	0.000803	0.00725	CbGeAlD
Triazolam—Syncope—Procarbazine—brain cancer	0.000801	0.0056	CcSEcCtD
Triazolam—GABRG2—pituitary gland—brain cancer	0.000797	0.00719	CbGeAlD
Triazolam—Muscular weakness—Temozolomide—brain cancer	0.000791	0.00553	CcSEcCtD
Triazolam—GABRD—central nervous system—brain cancer	0.00079	0.00712	CbGeAlD
Triazolam—Hallucination—Hydroxyurea—brain cancer	0.00079	0.00553	CcSEcCtD
Triazolam—Loss of consciousness—Procarbazine—brain cancer	0.000785	0.00549	CcSEcCtD
Triazolam—GABRD—cerebellum—brain cancer	0.000772	0.00696	CbGeAlD
Triazolam—Hypertension—Procarbazine—brain cancer	0.000771	0.00539	CcSEcCtD
Triazolam—GABRB2—medulla oblongata—brain cancer	0.000769	0.00694	CbGeAlD
Triazolam—GABRG2—medulla oblongata—brain cancer	0.000769	0.00694	CbGeAlD
Triazolam—GABRG1—central nervous system—brain cancer	0.00076	0.00686	CbGeAlD
Triazolam—GABRA3—endocrine gland—brain cancer	0.000758	0.00683	CbGeAlD
Triazolam—Anxiety—Procarbazine—brain cancer	0.000758	0.0053	CcSEcCtD
Triazolam—GABRG3—brain—brain cancer	0.000757	0.00683	CbGeAlD
Triazolam—GABRA6—central nervous system—brain cancer	0.000756	0.00682	CbGeAlD
Triazolam—Sweating increased—Temozolomide—brain cancer	0.000755	0.00528	CcSEcCtD
Triazolam—GABRB3—telencephalon—brain cancer	0.000752	0.00678	CbGeAlD
Triazolam—GABRA3—head—brain cancer	0.000748	0.00675	CbGeAlD
Triazolam—Dry mouth—Procarbazine—brain cancer	0.000743	0.0052	CcSEcCtD
Triazolam—GABRG1—cerebellum—brain cancer	0.000743	0.0067	CbGeAlD
Triazolam—GABRA6—cerebellum—brain cancer	0.000739	0.00666	CbGeAlD
Triazolam—GABRB1—central nervous system—brain cancer	0.000737	0.00665	CbGeAlD
Triazolam—Confusional state—Procarbazine—brain cancer	0.000735	0.00514	CcSEcCtD
Triazolam—GABRA5—central nervous system—brain cancer	0.000733	0.00661	CbGeAlD
Triazolam—Vomiting—Lomustine—brain cancer	0.00073	0.00511	CcSEcCtD
Triazolam—GABRA4—head—brain cancer	0.000729	0.00657	CbGeAlD
Triazolam—Oedema—Procarbazine—brain cancer	0.000729	0.0051	CcSEcCtD
Triazolam—Dysuria—Temozolomide—brain cancer	0.000724	0.00507	CcSEcCtD
Triazolam—GABRP—head—brain cancer	0.000724	0.00653	CbGeAlD
Triazolam—GABRE—pituitary gland—brain cancer	0.000722	0.00651	CbGeAlD
Triazolam—GABRR1—brain—brain cancer	0.000722	0.00651	CbGeAlD
Triazolam—GABRB1—cerebellum—brain cancer	0.000721	0.0065	CbGeAlD
Triazolam—Shock—Procarbazine—brain cancer	0.000717	0.00502	CcSEcCtD
Triazolam—Tachycardia—Procarbazine—brain cancer	0.000711	0.00498	CcSEcCtD
Triazolam—Hyperhidrosis—Procarbazine—brain cancer	0.000704	0.00493	CcSEcCtD
Triazolam—GABRB2—midbrain—brain cancer	0.000703	0.00634	CbGeAlD
Triazolam—GABRG2—midbrain—brain cancer	0.000703	0.00634	CbGeAlD
Triazolam—Stomatitis—Carmustine—brain cancer	0.000697	0.00488	CcSEcCtD
Triazolam—Anorexia—Procarbazine—brain cancer	0.000695	0.00486	CcSEcCtD
Triazolam—TSPO—gonad—brain cancer	0.000691	0.00623	CbGeAlD
Triazolam—Erythema—Hydroxyurea—brain cancer	0.000691	0.00484	CcSEcCtD
Triazolam—GABRG2—spinal cord—brain cancer	0.000686	0.00619	CbGeAlD
Triazolam—GABRB2—spinal cord—brain cancer	0.000686	0.00619	CbGeAlD
Triazolam—GABRA3—central nervous system—brain cancer	0.000683	0.00616	CbGeAlD
Triazolam—Nausea—Lomustine—brain cancer	0.000682	0.00477	CcSEcCtD
Triazolam—GABRA1—medulla oblongata—brain cancer	0.000679	0.00613	CbGeAlD
Triazolam—TSPO—pituitary gland—brain cancer	0.000674	0.00608	CbGeAlD
Triazolam—Stomatitis—Temozolomide—brain cancer	0.000673	0.00471	CcSEcCtD
Triazolam—GABRA4—central nervous system—brain cancer	0.000665	0.006	CbGeAlD
Triazolam—Insomnia—Procarbazine—brain cancer	0.000659	0.00461	CcSEcCtD
Triazolam—Paraesthesia—Procarbazine—brain cancer	0.000654	0.00458	CcSEcCtD
Triazolam—TSPO—medulla oblongata—brain cancer	0.000651	0.00587	CbGeAlD
Triazolam—GABRA4—cerebellum—brain cancer	0.00065	0.00586	CbGeAlD
Triazolam—Somnolence—Procarbazine—brain cancer	0.000648	0.00453	CcSEcCtD
Triazolam—Cramp muscle—Etoposide—brain cancer	0.000646	0.00452	CcSEcCtD
Triazolam—Ill-defined disorder—Hydroxyurea—brain cancer	0.000641	0.00449	CcSEcCtD
Triazolam—Hallucination—Carmustine—brain cancer	0.000639	0.00447	CcSEcCtD
Triazolam—Decreased appetite—Procarbazine—brain cancer	0.000633	0.00443	CcSEcCtD
Triazolam—Fatigue—Procarbazine—brain cancer	0.000628	0.0044	CcSEcCtD
Triazolam—GABRB3—gonad—brain cancer	0.000628	0.00566	CbGeAlD
Triazolam—GABRD—brain—brain cancer	0.000627	0.00566	CbGeAlD
Triazolam—Malaise—Hydroxyurea—brain cancer	0.000623	0.00436	CcSEcCtD
Triazolam—Pain—Procarbazine—brain cancer	0.000623	0.00436	CcSEcCtD
Triazolam—Constipation—Procarbazine—brain cancer	0.000623	0.00436	CcSEcCtD
Triazolam—GABRA1—midbrain—brain cancer	0.000621	0.0056	CbGeAlD
Triazolam—Visual impairment—Carmustine—brain cancer	0.000618	0.00433	CcSEcCtD
Triazolam—Hallucination—Temozolomide—brain cancer	0.000617	0.00432	CcSEcCtD
Triazolam—GABRB3—pituitary gland—brain cancer	0.000612	0.00552	CbGeAlD
Triazolam—GABRB2—head—brain cancer	0.00061	0.0055	CbGeAlD
Triazolam—GABRG2—head—brain cancer	0.00061	0.0055	CbGeAlD
Triazolam—GABRA1—spinal cord—brain cancer	0.000606	0.00546	CbGeAlD
Triazolam—Sweating increased—Etoposide—brain cancer	0.000604	0.00423	CcSEcCtD
Triazolam—GABRG1—brain—brain cancer	0.000604	0.00544	CbGeAlD
Triazolam—Feeling abnormal—Procarbazine—brain cancer	0.000601	0.0042	CcSEcCtD
Triazolam—GABRA6—brain—brain cancer	0.0006	0.00541	CbGeAlD
Triazolam—Visual impairment—Temozolomide—brain cancer	0.000598	0.00418	CcSEcCtD
Triazolam—Gastrointestinal pain—Procarbazine—brain cancer	0.000596	0.00417	CcSEcCtD
Triazolam—TSPO—midbrain—brain cancer	0.000595	0.00536	CbGeAlD
Triazolam—GABRB3—medulla oblongata—brain cancer	0.000591	0.00533	CbGeAlD
Triazolam—GABRB1—brain—brain cancer	0.000585	0.00528	CbGeAlD
Triazolam—GABRA5—brain—brain cancer	0.000582	0.00525	CbGeAlD
Triazolam—Discomfort—Hydroxyurea—brain cancer	0.000581	0.00407	CcSEcCtD
Triazolam—TSPO—spinal cord—brain cancer	0.00058	0.00523	CbGeAlD
Triazolam—Tinnitus—Temozolomide—brain cancer	0.000578	0.00405	CcSEcCtD
Triazolam—Abdominal pain—Procarbazine—brain cancer	0.000576	0.00403	CcSEcCtD
Triazolam—Alprazolam—CYP2C9—brain cancer	0.00057	0.24	CrCbGaD
Triazolam—Oedema—Hydroxyurea—brain cancer	0.000564	0.00395	CcSEcCtD
Triazolam—Erythema—Carmustine—brain cancer	0.000559	0.00391	CcSEcCtD
Triazolam—GABRA2—head—brain cancer	0.000557	0.00502	CbGeAlD
Triazolam—GABRB2—central nervous system—brain cancer	0.000557	0.00502	CbGeAlD
Triazolam—GABRG2—central nervous system—brain cancer	0.000557	0.00502	CbGeAlD
Triazolam—Quazepam—CYP2C9—brain cancer	0.000552	0.232	CrCbGaD
Triazolam—GABRE—head—brain cancer	0.000552	0.00498	CbGeAlD
Triazolam—GABRG2—cerebellum—brain cancer	0.000544	0.00491	CbGeAlD
Triazolam—GABRB2—cerebellum—brain cancer	0.000544	0.00491	CbGeAlD
Triazolam—GABRA3—brain—brain cancer	0.000542	0.00489	CbGeAlD
Triazolam—GABRB3—midbrain—brain cancer	0.00054	0.00487	CbGeAlD
Triazolam—Erythema—Temozolomide—brain cancer	0.00054	0.00378	CcSEcCtD
Triazolam—Jaundice—Etoposide—brain cancer	0.000539	0.00377	CcSEcCtD
Triazolam—Stomatitis—Etoposide—brain cancer	0.000539	0.00377	CcSEcCtD
Triazolam—GABRA1—head—brain cancer	0.000538	0.00486	CbGeAlD
Triazolam—Anorexia—Hydroxyurea—brain cancer	0.000538	0.00376	CcSEcCtD
Triazolam—Hypersensitivity—Procarbazine—brain cancer	0.000537	0.00376	CcSEcCtD
Triazolam—Dysgeusia—Temozolomide—brain cancer	0.000529	0.0037	CcSEcCtD
Triazolam—GABRA4—brain—brain cancer	0.000528	0.00476	CbGeAlD
Triazolam—GABRB3—spinal cord—brain cancer	0.000527	0.00475	CbGeAlD
Triazolam—Tremor—Carmustine—brain cancer	0.000523	0.00366	CcSEcCtD
Triazolam—Asthenia—Procarbazine—brain cancer	0.000523	0.00366	CcSEcCtD
Triazolam—TSPO—endocrine gland—brain cancer	0.000522	0.00471	CbGeAlD
Triazolam—Flunitrazepam—CYP2C9—brain cancer	0.000522	0.219	CrCbGaD
Triazolam—TSPO—head—brain cancer	0.000516	0.00465	CbGeAlD
Triazolam—Pruritus—Procarbazine—brain cancer	0.000516	0.00361	CcSEcCtD
Triazolam—Agitation—Carmustine—brain cancer	0.000513	0.00359	CcSEcCtD
Triazolam—GABRA2—central nervous system—brain cancer	0.000508	0.00459	CbGeAlD
Triazolam—Tremor—Temozolomide—brain cancer	0.000506	0.00354	CcSEcCtD
Triazolam—GABRE—central nervous system—brain cancer	0.000504	0.00455	CbGeAlD
Triazolam—Dyspnoea—Hydroxyurea—brain cancer	0.000503	0.00352	CcSEcCtD
Triazolam—Somnolence—Hydroxyurea—brain cancer	0.000501	0.00351	CcSEcCtD
Triazolam—Ill-defined disorder—Temozolomide—brain cancer	0.000501	0.0035	CcSEcCtD
Triazolam—Diarrhoea—Procarbazine—brain cancer	0.000499	0.00349	CcSEcCtD
Triazolam—GABRA2—cerebellum—brain cancer	0.000497	0.00448	CbGeAlD
Triazolam—Agitation—Temozolomide—brain cancer	0.000496	0.00347	CcSEcCtD
Triazolam—GABRA1—central nervous system—brain cancer	0.000491	0.00443	CbGeAlD
Triazolam—Decreased appetite—Hydroxyurea—brain cancer	0.00049	0.00343	CcSEcCtD
Triazolam—Malaise—Temozolomide—brain cancer	0.000487	0.00341	CcSEcCtD
Triazolam—Fatigue—Hydroxyurea—brain cancer	0.000486	0.0034	CcSEcCtD
Triazolam—Hypertension—Carmustine—brain cancer	0.000482	0.00337	CcSEcCtD
Triazolam—Pain—Hydroxyurea—brain cancer	0.000482	0.00337	CcSEcCtD
Triazolam—Constipation—Hydroxyurea—brain cancer	0.000482	0.00337	CcSEcCtD
Triazolam—Dizziness—Procarbazine—brain cancer	0.000482	0.00337	CcSEcCtD
Triazolam—GABRA1—cerebellum—brain cancer	0.00048	0.00433	CbGeAlD
Triazolam—Palpitations—Temozolomide—brain cancer	0.000477	0.00334	CcSEcCtD
Triazolam—Chest pain—Carmustine—brain cancer	0.000476	0.00333	CcSEcCtD
Triazolam—GABRB3—endocrine gland—brain cancer	0.000474	0.00428	CbGeAlD
Triazolam—Anxiety—Carmustine—brain cancer	0.000474	0.00332	CcSEcCtD
Triazolam—TSPO—central nervous system—brain cancer	0.000471	0.00424	CbGeAlD
Triazolam—GABRB3—head—brain cancer	0.000468	0.00422	CbGeAlD
Triazolam—Hypertension—Temozolomide—brain cancer	0.000466	0.00326	CcSEcCtD
Triazolam—Feeling abnormal—Hydroxyurea—brain cancer	0.000465	0.00325	CcSEcCtD
Triazolam—Vomiting—Procarbazine—brain cancer	0.000463	0.00324	CcSEcCtD
Triazolam—CYP2C8—pituitary gland—brain cancer	0.000463	0.00417	CbGeAlD
Triazolam—TSPO—cerebellum—brain cancer	0.00046	0.00415	CbGeAlD
Triazolam—Confusional state—Carmustine—brain cancer	0.00046	0.00322	CcSEcCtD
Triazolam—Dermatitis—Procarbazine—brain cancer	0.000459	0.00321	CcSEcCtD
Triazolam—Anxiety—Temozolomide—brain cancer	0.000458	0.0032	CcSEcCtD
Triazolam—Headache—Procarbazine—brain cancer	0.000457	0.00319	CcSEcCtD
Triazolam—Oedema—Carmustine—brain cancer	0.000456	0.00319	CcSEcCtD
Triazolam—Discomfort—Temozolomide—brain cancer	0.000454	0.00318	CcSEcCtD
Triazolam—Dry mouth—Temozolomide—brain cancer	0.000449	0.00315	CcSEcCtD
Triazolam—Tachycardia—Carmustine—brain cancer	0.000445	0.00311	CcSEcCtD
Triazolam—Confusional state—Temozolomide—brain cancer	0.000444	0.00311	CcSEcCtD
Triazolam—GABRG2—brain—brain cancer	0.000442	0.00398	CbGeAlD
Triazolam—GABRB2—brain—brain cancer	0.000442	0.00398	CbGeAlD
Triazolam—Oedema—Temozolomide—brain cancer	0.000441	0.00308	CcSEcCtD
Triazolam—Anorexia—Carmustine—brain cancer	0.000435	0.00304	CcSEcCtD
Triazolam—Nausea—Procarbazine—brain cancer	0.000433	0.00303	CcSEcCtD
Triazolam—GABRB3—central nervous system—brain cancer	0.000427	0.00385	CbGeAlD
Triazolam—Hyperhidrosis—Temozolomide—brain cancer	0.000426	0.00298	CcSEcCtD
Triazolam—Dysgeusia—Etoposide—brain cancer	0.000423	0.00296	CcSEcCtD
Triazolam—Anorexia—Temozolomide—brain cancer	0.00042	0.00294	CcSEcCtD
Triazolam—GABRB3—cerebellum—brain cancer	0.000418	0.00377	CbGeAlD
Triazolam—Hypersensitivity—Hydroxyurea—brain cancer	0.000416	0.00291	CcSEcCtD
Triazolam—Muscle spasms—Etoposide—brain cancer	0.000415	0.00291	CcSEcCtD
Triazolam—Insomnia—Carmustine—brain cancer	0.000412	0.00289	CcSEcCtD
Triazolam—Paraesthesia—Carmustine—brain cancer	0.000409	0.00286	CcSEcCtD
Triazolam—Dyspnoea—Carmustine—brain cancer	0.000406	0.00284	CcSEcCtD
Triazolam—Somnolence—Carmustine—brain cancer	0.000405	0.00284	CcSEcCtD
Triazolam—Asthenia—Hydroxyurea—brain cancer	0.000405	0.00283	CcSEcCtD
Triazolam—GABRA2—brain—brain cancer	0.000404	0.00364	CbGeAlD
Triazolam—Ill-defined disorder—Etoposide—brain cancer	0.000401	0.0028	CcSEcCtD
Triazolam—Temazepam—CYP2C9—brain cancer	0.0004	0.168	CrCbGaD
Triazolam—GABRE—brain—brain cancer	0.0004	0.00361	CbGeAlD
Triazolam—Insomnia—Temozolomide—brain cancer	0.000398	0.00279	CcSEcCtD
Triazolam—Decreased appetite—Carmustine—brain cancer	0.000396	0.00277	CcSEcCtD
Triazolam—Paraesthesia—Temozolomide—brain cancer	0.000396	0.00277	CcSEcCtD
Triazolam—Dyspnoea—Temozolomide—brain cancer	0.000393	0.00275	CcSEcCtD
Triazolam—Somnolence—Temozolomide—brain cancer	0.000392	0.00274	CcSEcCtD
Triazolam—GABRA1—brain—brain cancer	0.00039	0.00352	CbGeAlD
Triazolam—Pain—Carmustine—brain cancer	0.00039	0.00273	CcSEcCtD
Triazolam—Constipation—Carmustine—brain cancer	0.00039	0.00273	CcSEcCtD
Triazolam—Malaise—Etoposide—brain cancer	0.00039	0.00273	CcSEcCtD
Triazolam—Diarrhoea—Hydroxyurea—brain cancer	0.000386	0.0027	CcSEcCtD
Triazolam—Decreased appetite—Temozolomide—brain cancer	0.000383	0.00268	CcSEcCtD
Triazolam—Fatigue—Temozolomide—brain cancer	0.00038	0.00266	CcSEcCtD
Triazolam—Loss of consciousness—Etoposide—brain cancer	0.00038	0.00266	CcSEcCtD
Triazolam—Pain—Temozolomide—brain cancer	0.000377	0.00264	CcSEcCtD
Triazolam—Constipation—Temozolomide—brain cancer	0.000377	0.00264	CcSEcCtD
Triazolam—Feeling abnormal—Carmustine—brain cancer	0.000376	0.00263	CcSEcCtD
Triazolam—TSPO—brain—brain cancer	0.000374	0.00337	CbGeAlD
Triazolam—Hypertension—Etoposide—brain cancer	0.000373	0.00261	CcSEcCtD
Triazolam—Dizziness—Hydroxyurea—brain cancer	0.000373	0.00261	CcSEcCtD
Triazolam—Gastrointestinal pain—Carmustine—brain cancer	0.000373	0.00261	CcSEcCtD
Triazolam—Chest pain—Etoposide—brain cancer	0.000368	0.00257	CcSEcCtD
Triazolam—Discomfort—Etoposide—brain cancer	0.000363	0.00254	CcSEcCtD
Triazolam—Feeling abnormal—Temozolomide—brain cancer	0.000363	0.00254	CcSEcCtD
Triazolam—Abdominal pain—Carmustine—brain cancer	0.00036	0.00252	CcSEcCtD
Triazolam—Gastrointestinal pain—Temozolomide—brain cancer	0.00036	0.00252	CcSEcCtD
Triazolam—Vomiting—Hydroxyurea—brain cancer	0.000359	0.00251	CcSEcCtD
Triazolam—CYP2C8—endocrine gland—brain cancer	0.000358	0.00323	CbGeAlD
Triazolam—Confusional state—Etoposide—brain cancer	0.000355	0.00249	CcSEcCtD
Triazolam—Dermatitis—Hydroxyurea—brain cancer	0.000355	0.00249	CcSEcCtD
Triazolam—Headache—Hydroxyurea—brain cancer	0.000353	0.00247	CcSEcCtD
Triazolam—Abdominal pain—Temozolomide—brain cancer	0.000348	0.00244	CcSEcCtD
Triazolam—Tachycardia—Etoposide—brain cancer	0.000344	0.00241	CcSEcCtD
Triazolam—Hyperhidrosis—Etoposide—brain cancer	0.000341	0.00238	CcSEcCtD
Triazolam—GABRB3—brain—brain cancer	0.000339	0.00306	CbGeAlD
Triazolam—Anorexia—Etoposide—brain cancer	0.000336	0.00235	CcSEcCtD
Triazolam—Hypersensitivity—Carmustine—brain cancer	0.000336	0.00235	CcSEcCtD
Triazolam—Nausea—Hydroxyurea—brain cancer	0.000335	0.00234	CcSEcCtD
Triazolam—Diazepam—CYP2C9—brain cancer	0.000333	0.14	CrCbGaD
Triazolam—Asthenia—Carmustine—brain cancer	0.000327	0.00229	CcSEcCtD
Triazolam—Hypersensitivity—Temozolomide—brain cancer	0.000325	0.00227	CcSEcCtD
Triazolam—CYP3A5—endocrine gland—brain cancer	0.000324	0.00292	CbGeAlD
Triazolam—CYP2C9—endocrine gland—brain cancer	0.000318	0.00287	CbGeAlD
Triazolam—Paraesthesia—Etoposide—brain cancer	0.000317	0.00222	CcSEcCtD
Triazolam—Asthenia—Temozolomide—brain cancer	0.000316	0.00221	CcSEcCtD
Triazolam—Dyspnoea—Etoposide—brain cancer	0.000314	0.0022	CcSEcCtD
Triazolam—Somnolence—Etoposide—brain cancer	0.000313	0.00219	CcSEcCtD
Triazolam—Diarrhoea—Carmustine—brain cancer	0.000312	0.00218	CcSEcCtD
Triazolam—Pruritus—Temozolomide—brain cancer	0.000312	0.00218	CcSEcCtD
Triazolam—Decreased appetite—Etoposide—brain cancer	0.000306	0.00214	CcSEcCtD
Triazolam—Fatigue—Etoposide—brain cancer	0.000304	0.00213	CcSEcCtD
Triazolam—Dizziness—Carmustine—brain cancer	0.000301	0.00211	CcSEcCtD
Triazolam—Pain—Etoposide—brain cancer	0.000301	0.00211	CcSEcCtD
Triazolam—Constipation—Etoposide—brain cancer	0.000301	0.00211	CcSEcCtD
Triazolam—Diarrhoea—Temozolomide—brain cancer	0.000301	0.00211	CcSEcCtD
Triazolam—Dizziness—Temozolomide—brain cancer	0.000291	0.00204	CcSEcCtD
Triazolam—Feeling abnormal—Etoposide—brain cancer	0.000291	0.00203	CcSEcCtD
Triazolam—Vomiting—Carmustine—brain cancer	0.00029	0.00203	CcSEcCtD
Triazolam—Gastrointestinal pain—Etoposide—brain cancer	0.000288	0.00202	CcSEcCtD
Triazolam—Dermatitis—Carmustine—brain cancer	0.000287	0.00201	CcSEcCtD
Triazolam—Headache—Carmustine—brain cancer	0.000286	0.002	CcSEcCtD
Triazolam—Vomiting—Temozolomide—brain cancer	0.00028	0.00196	CcSEcCtD
Triazolam—Abdominal pain—Etoposide—brain cancer	0.000279	0.00195	CcSEcCtD
Triazolam—Dermatitis—Temozolomide—brain cancer	0.000278	0.00194	CcSEcCtD
Triazolam—Headache—Temozolomide—brain cancer	0.000276	0.00193	CcSEcCtD
Triazolam—Nausea—Carmustine—brain cancer	0.000271	0.00189	CcSEcCtD
Triazolam—Nausea—Temozolomide—brain cancer	0.000262	0.00183	CcSEcCtD
Triazolam—Hypersensitivity—Etoposide—brain cancer	0.00026	0.00182	CcSEcCtD
Triazolam—CYP2C8—brain—brain cancer	0.000256	0.00231	CbGeAlD
Triazolam—Asthenia—Etoposide—brain cancer	0.000253	0.00177	CcSEcCtD
Triazolam—Pruritus—Etoposide—brain cancer	0.000249	0.00175	CcSEcCtD
Triazolam—CYP3A4—endocrine gland—brain cancer	0.000243	0.00219	CbGeAlD
Triazolam—Diarrhoea—Etoposide—brain cancer	0.000241	0.00169	CcSEcCtD
Triazolam—Dizziness—Etoposide—brain cancer	0.000233	0.00163	CcSEcCtD
Triazolam—Vomiting—Etoposide—brain cancer	0.000224	0.00157	CcSEcCtD
Triazolam—Dermatitis—Etoposide—brain cancer	0.000222	0.00155	CcSEcCtD
Triazolam—Headache—Etoposide—brain cancer	0.000221	0.00155	CcSEcCtD
Triazolam—CYP3A4—central nervous system—brain cancer	0.000219	0.00197	CbGeAlD
Triazolam—Nausea—Etoposide—brain cancer	0.000209	0.00147	CcSEcCtD
Triazolam—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	3.67e-05	0.0542	CbGpPWpGaD
Triazolam—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	3.3e-05	0.0487	CbGpPWpGaD
Triazolam—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	3e-05	0.0443	CbGpPWpGaD
Triazolam—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	2.56e-05	0.0378	CbGpPWpGaD
Triazolam—CYP3A7—Xenobiotics—CYP2C9—brain cancer	2.53e-05	0.0374	CbGpPWpGaD
Triazolam—CYP3A5—Xenobiotics—CYP2C9—brain cancer	1.83e-05	0.027	CbGpPWpGaD
Triazolam—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	1.76e-05	0.026	CbGpPWpGaD
Triazolam—GABRQ—Orphan transporters—S100A10—brain cancer	1.6e-05	0.0237	CbGpPWpGaD
Triazolam—CYP2C8—Xenobiotics—CYP2C9—brain cancer	1.58e-05	0.0234	CbGpPWpGaD
Triazolam—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	1.52e-05	0.0225	CbGpPWpGaD
Triazolam—GABRG3—Orphan transporters—S100A10—brain cancer	1.32e-05	0.0195	CbGpPWpGaD
Triazolam—GABRB1—Orphan transporters—S100A10—brain cancer	1.3e-05	0.0192	CbGpPWpGaD
Triazolam—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	1.26e-05	0.0186	CbGpPWpGaD
Triazolam—GABRA6—Orphan transporters—S100A10—brain cancer	1.23e-05	0.0182	CbGpPWpGaD
Triazolam—GABRA4—Orphan transporters—S100A10—brain cancer	1.21e-05	0.0179	CbGpPWpGaD
Triazolam—GABRB2—Orphan transporters—S100A10—brain cancer	1.11e-05	0.0164	CbGpPWpGaD
Triazolam—GABRA5—Orphan transporters—S100A10—brain cancer	1.08e-05	0.0159	CbGpPWpGaD
Triazolam—GABRA3—Orphan transporters—S100A10—brain cancer	1.06e-05	0.0157	CbGpPWpGaD
Triazolam—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	1.05e-05	0.0155	CbGpPWpGaD
Triazolam—GABRA2—Orphan transporters—S100A10—brain cancer	1.04e-05	0.0154	CbGpPWpGaD
Triazolam—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	1.04e-05	0.0153	CbGpPWpGaD
Triazolam—GABRB3—Orphan transporters—S100A10—brain cancer	1.03e-05	0.0153	CbGpPWpGaD
Triazolam—GABRG2—Orphan transporters—S100A10—brain cancer	1.02e-05	0.015	CbGpPWpGaD
Triazolam—GABRA1—Orphan transporters—S100A10—brain cancer	8.88e-06	0.0131	CbGpPWpGaD
Triazolam—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	8.52e-06	0.0126	CbGpPWpGaD
Triazolam—CYP3A4—Xenobiotics—CYP2C9—brain cancer	8.51e-06	0.0126	CbGpPWpGaD
Triazolam—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	8.18e-06	0.0121	CbGpPWpGaD
Triazolam—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	7.61e-06	0.0112	CbGpPWpGaD
Triazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	7.6e-06	0.0112	CbGpPWpGaD
Triazolam—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	7.5e-06	0.0111	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—NTRK3—brain cancer	7.42e-06	0.011	CbGpPWpGaD
Triazolam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	6.58e-06	0.00972	CbGpPWpGaD
Triazolam—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	6.49e-06	0.00959	CbGpPWpGaD
Triazolam—CYP3A5—Irinotecan Pathway—APC—brain cancer	6.45e-06	0.00953	CbGpPWpGaD
Triazolam—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	6.16e-06	0.0091	CbGpPWpGaD
Triazolam—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	5.84e-06	0.00863	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—HES5—brain cancer	5.78e-06	0.00854	CbGpPWpGaD
Triazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	5.56e-06	0.00822	CbGpPWpGaD
Triazolam—GABRR1—Ion channel transport—TRPC6—brain cancer	5.44e-06	0.00804	CbGpPWpGaD
Triazolam—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	5.33e-06	0.00788	CbGpPWpGaD
Triazolam—GABRR2—Ion channel transport—TRPC6—brain cancer	5.19e-06	0.00767	CbGpPWpGaD
Triazolam—GABRQ—Ion channel transport—TRPC6—brain cancer	5.19e-06	0.00767	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—CYP2C9—brain cancer	4.53e-06	0.00668	CbGpPWpGaD
Triazolam—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	4.46e-06	0.00659	CbGpPWpGaD
Triazolam—GABRG3—Ion channel transport—TRPC6—brain cancer	4.28e-06	0.00632	CbGpPWpGaD
Triazolam—GABRB1—Ion channel transport—TRPC6—brain cancer	4.21e-06	0.00622	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—S100A10—brain cancer	4.1e-06	0.00606	CbGpPWpGaD
Triazolam—GABRA6—Ion channel transport—TRPC6—brain cancer	3.99e-06	0.00589	CbGpPWpGaD
Triazolam—GABRA4—Ion channel transport—TRPC6—brain cancer	3.94e-06	0.00581	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—S100A10—brain cancer	3.91e-06	0.00578	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—S100A10—brain cancer	3.91e-06	0.00578	CbGpPWpGaD
Triazolam—GABRB2—Ion channel transport—TRPC6—brain cancer	3.6e-06	0.00532	CbGpPWpGaD
Triazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	3.53e-06	0.00522	CbGpPWpGaD
Triazolam—GABRA5—Ion channel transport—TRPC6—brain cancer	3.5e-06	0.00517	CbGpPWpGaD
Triazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	3.49e-06	0.00515	CbGpPWpGaD
Triazolam—GABRA3—Ion channel transport—TRPC6—brain cancer	3.43e-06	0.00507	CbGpPWpGaD
Triazolam—GABRA2—Ion channel transport—TRPC6—brain cancer	3.37e-06	0.00498	CbGpPWpGaD
Triazolam—GABRB3—Ion channel transport—TRPC6—brain cancer	3.35e-06	0.00495	CbGpPWpGaD
Triazolam—GABRG2—Ion channel transport—TRPC6—brain cancer	3.29e-06	0.00486	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—CYP2C9—brain cancer	3.27e-06	0.00483	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	3.23e-06	0.00477	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—S100A10—brain cancer	3.22e-06	0.00476	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—S100A10—brain cancer	3.17e-06	0.00469	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—S100A10—brain cancer	3e-06	0.00444	CbGpPWpGaD
Triazolam—CYP3A4—Irinotecan Pathway—APC—brain cancer	3e-06	0.00443	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—S100A10—brain cancer	2.97e-06	0.00438	CbGpPWpGaD
Triazolam—GABRA1—Ion channel transport—TRPC6—brain cancer	2.88e-06	0.00425	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	2.86e-06	0.00423	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—CYP2C9—brain cancer	2.83e-06	0.00419	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	2.79e-06	0.00413	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—S100A10—brain cancer	2.71e-06	0.00401	CbGpPWpGaD
Triazolam—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	2.66e-06	0.00393	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—S100A10—brain cancer	2.64e-06	0.00389	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—S100A10—brain cancer	2.59e-06	0.00382	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—S100A10—brain cancer	2.54e-06	0.00376	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—S100A10—brain cancer	2.53e-06	0.00373	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—S100A10—brain cancer	2.48e-06	0.00366	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—ESR2—brain cancer	2.46e-06	0.00364	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—SPP1—brain cancer	2.19e-06	0.00324	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—S100A10—brain cancer	2.17e-06	0.0032	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—IRS2—brain cancer	1.98e-06	0.00293	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—HES1—brain cancer	1.91e-06	0.00282	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.89e-06	0.0028	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.81e-06	0.00267	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—TRPC6—brain cancer	1.81e-06	0.00267	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—APC—brain cancer	1.75e-06	0.00259	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP2C9—brain cancer	1.52e-06	0.00225	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	1.5e-06	0.00222	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—TRPC6—brain cancer	1.49e-06	0.0022	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.47e-06	0.00217	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—TRPC6—brain cancer	1.39e-06	0.00205	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—TRPC6—brain cancer	1.37e-06	0.00202	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—RELA—brain cancer	1.37e-06	0.00202	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.25e-06	0.00185	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—TRPC6—brain cancer	1.22e-06	0.0018	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—TRPC6—brain cancer	1.2e-06	0.00177	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—CTNNB1—brain cancer	1.19e-06	0.00176	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.17e-06	0.00173	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—TRPC6—brain cancer	1.17e-06	0.00172	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.15e-06	0.00169	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.09e-06	0.00161	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—STAT3—brain cancer	1.04e-06	0.00153	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—TRPC6—brain cancer	1e-06	0.00148	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	9.58e-07	0.00142	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—brain cancer	8.44e-07	0.00125	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.96e-07	0.00118	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP2C9—brain cancer	7.74e-07	0.00114	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—BSG—brain cancer	6.58e-07	0.000972	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.47e-07	0.000956	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—IDH1—brain cancer	5.66e-07	0.000836	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2C9—brain cancer	5.59e-07	0.000826	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2C9—brain cancer	4.85e-07	0.000716	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—BSG—brain cancer	4.76e-07	0.000703	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ENO2—brain cancer	4.47e-07	0.000661	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—BSG—brain cancer	4.12e-07	0.000609	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—IDH1—brain cancer	4.09e-07	0.000604	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—IDH1—brain cancer	3.54e-07	0.000523	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—BSG—brain cancer	3.35e-07	0.000495	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ENO2—brain cancer	3.23e-07	0.000478	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.88e-07	0.000426	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—IDH1—brain cancer	2.88e-07	0.000426	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ENO2—brain cancer	2.8e-07	0.000414	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2C9—brain cancer	2.6e-07	0.000384	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.35e-07	0.000347	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ENO2—brain cancer	2.28e-07	0.000337	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—BSG—brain cancer	2.21e-07	0.000327	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CG—brain cancer	2.05e-07	0.000303	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—IDH1—brain cancer	1.9e-07	0.000281	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ENO2—brain cancer	1.5e-07	0.000222	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CG—brain cancer	1.48e-07	0.000219	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CG—brain cancer	1.28e-07	0.00019	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CG—brain cancer	1.05e-07	0.000154	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CG—brain cancer	6.9e-08	0.000102	CbGpPWpGaD
